IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal

Hypoglycemia is a rare paraneoplastic manifestation of patients with neoplasms. Hypoglycemia can be induced by several causes, including an aberrant increase of hypoglycemic agents and adrenal insufficiency. Sorafenib is the first agent to demonstrate a survival benefit in the treatment of advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Okushin, Kazuya, Asaoka, Yoshinari, Fukuda, Izumi, Fujiwara, Naoto, Minami, Tatsuya, Sato, Masaya, Mikami, Shintaro, Uchino, Koji, Enooku, Kenichiro, Kondo, Yuji, Tateishi, Ryosuke, Goto, Tadashi, Shiina, Shuichiro, Yoshida, Haruhiko, Koike, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Published online: December, 2012
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551420/
https://www.ncbi.nlm.nih.gov/pubmed/23341802
http://dx.doi.org/10.1159/000346462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551420/
https://www.ncbi.nlm.nih.gov/pubmed/23341802
http://dx.doi.org/10.1159/000346462

Ejemplares similares